Allergopharma is one of the leading companies in the field of allergen immunotherapy (AIT). We provide innovative products for the causal treatment of IgE-mediated allergic diseases and are one of the market leaders for subcutaneous AIT. Our portfolio includes a diverse spectrum of approved allergen products that meet high quality standards. We offer high-dose, hypoallergenic, standardized products for the specific immunotherapy of pollen and mite allergies. These allergoids have special focus in our product portfolio and constitute a cornerstone in our integrated health approach for patients suffering from these conditions. For an effective treatment, reliable diagnosis is key. Allergopharma offers a broad range of diagnostics in the field of allergies with more than 100 single allergens, providing physicians with the specific tools needed to identify the substances causing an allergy. In addition, we provide individual allergen extracts on a named patient basis, which are needed to treat less frequent allergies _ personalized medicine is a reality for us for many years already. Products of Allergopharma are available in more than 20 markets worldwide. Across the different countries, we have own affiliates _ either Allergopharma or Merck affiliates _ or work with distribution partners. Being a business unit of Merck, we have access to over 150 markets worldwide and will strategically broaden our international reach in the coming years. For more information, please visit our website: https://www.allergopharma.com/home/ https://www.allergopharma.com/imprint/